contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Stille develops, manufactures and markets medical devices for specialist surgeons. Priority areas are surgical instruments and special tables for cardiovascular surgery, gynecology and urology. The company's products are used by users on a global level. In addition to its core business, it also offers instrument care training. Stille was originally founded in 1841 and has its headquarters in Eskilstuna.

Stille

Stille AB (publ) publishes the report for the fourth quarter and the full year of 2021. "Strong sales despite current market situation", summarizes Stille CEO Hanna Ernestam Wilkman.Revenues...

<div class="abstract">Stille AB (publ) publishes the report for the fourth quarter and the full year of 2021. "Strong sales despite current market situation", summarizes Stille CEO Hanna Ernestam Wilkman.</div>Revenues for the fourth quarter reached 59.6 MSEK (45.0), including recently acquired S&amp;T whose sales exceeded expectations. Excluding the acquisition sales amounted to 44.0 MSEK despite challenges in the US for both business units.&nbsp;"To strengthen growth in the US-market, we have in December launched a new general surgery table, GS2®, in an exclusive collaboration with GE Healthcare, and signed an exclusive distribution agreement with Synovis Micro Companies Alliance for surgical instruments.", says Hanna Ernestam Wilkman and continues. "Operating profit in the fourth quarter has been affected by increased costs in the supply chain. Simultaneously, as part of our strategic efforts to refine our surgical tables business, we have made a depreciation of our stock which has resulted in a one-time cost."For the full year of 2021, Stille's revenue amounted to 187.1 MSEK, and operating profit to 20.1 MSEK (14.5)."Summarizing the full year, I can conclude that Stille, even without the acquired volume, never has had higher sales of surgical instruments than in 2021. Simultaneously, we know that healthcare systems worldwide have been forced to cancel surgeries affecting millions of people, and that this backlog of critical care services will drive the need for major investments in healthcare products and devices. This, coupled with the fact that Stille is in a good position for 2022, makes me greatly optimistic about our continued development", concludes Hanna Ernestam Wilkman.Strong Sales in Fourth Quarter&nbsp;<ul><li>Revenues amounted to 59.6 MSEK (45.0). Excluding the acquisition revenues amounted to 44.0 MSEK.</li><li>Gross margin amounted to 45.4 percent (45.7).</li><li>Operating profit amounted to 5.5 MSEK (8.7), equal to an operating margin of 9.2 percent (19.2). The operating profit was impacted with -1.1 MSEK (0.0) in transaction costs.</li><li>Net income amounted to 5.9 MSEK (4.4), equal to 9.9 percent (9.8) of revenues.</li><li>Cashflow from current operations amounted to 1.0 MSEK (19.6). Cashflow in the fourth quarter was affected by the, at the time of the acquisition, unresolved wage debt to key staff at S&amp;T of 11.5 MSEK.</li></ul>Dividend<ul><li></li></ul>The board of directors proposes the Annual General Meeting a dividend of 1.00 SEK per share (1.70).MSEK oct-dec oct-dec jan-dec jan-dec 2021 2020 2021 2020 Revenue 59.6 45.0 187.1 142.6 Operating Profit incl. transaction costs 5.5 8.7 20.1 14.5 Operating Margin incl. transaction costs. % 9.2 19.2 10.7 10.2 Profit Before Tax 4.8 5.7 20.6 10.8 Net Income 5.9 4.4 16.1 8.3 Earnings per Share. SEK 1.18 0.91 3.21 1.71Torshälla, February 17th, 2022.